• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双脱氧核苷类HIV逆转录酶抑制剂与药物相关肝毒性:一例报告

Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report.

作者信息

Lapadula Giuseppe, Izzo Ilaria, Costarelli Silvia, Cologni Giuliana, Bercich Luisa, Casari Salvatore, Gambarotti Marco, Torti Carlo

机构信息

Institute of Infectious and Tropical Diseases, University of Brescia, Italy.

出版信息

J Med Case Rep. 2007 May 8;1:19. doi: 10.1186/1752-1947-1-19.

DOI:10.1186/1752-1947-1-19
PMID:17488516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868747/
Abstract

This report regards the case of a 43 year-old HIV-positive woman who developed an episode of serious transaminase elevation during stavudine-including antiretroviral therapy. Diagnostic assessment ruled out hepatitis virus co-infection, alcohol abuse besides other possible causes of liver damage. No signs of lactic acidosis were present. Liver biopsy showed portal inflammatory infiltrate, spotty necrosis, vacuoles of macro- and micro-vesicular steatosis, acidophil and foamy hepatocytes degeneration with organelles clumping, poorly formed Mallory bodies and neutrophil granulocytes attraction (satellitosis). A dramatic improvement in liver function tests occurred when stavudine was discontinued and a new antiretroviral regimen with different nucleoside reverse transcriptase inhibitors was used. The importance of considering hepatotoxicity as an adverse event of HAART including stavudine, even in absence of other signs of mitochondrial toxicity should therefore be underlined. Liver biopsy may provide further important information regarding patients with severe transaminase elevation, for a better understanding of the etiology of liver damage.

摘要

本报告涉及一名43岁的HIV阳性女性病例,该患者在接受包含司他夫定的抗逆转录病毒治疗期间出现了严重的转氨酶升高。诊断评估排除了肝炎病毒合并感染、酒精滥用以及其他可能导致肝损伤的原因。未出现乳酸酸中毒迹象。肝活检显示门脉炎性浸润、散在坏死、大小泡性脂肪变性空泡、嗜酸性和泡沫状肝细胞变性伴细胞器聚集、形成不良的马洛里小体以及中性粒细胞浸润(卫星现象)。停用司他夫定并使用含不同核苷类逆转录酶抑制剂的新抗逆转录病毒方案后,肝功能检查出现显著改善。因此,即使在没有其他线粒体毒性迹象的情况下,也应强调将肝毒性视为包括司他夫定在内的高效抗逆转录病毒治疗(HAART)不良事件的重要性。肝活检可为严重转氨酶升高的患者提供进一步重要信息,以更好地了解肝损伤的病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e463/1868747/dd323691d524/1752-1947-1-19-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e463/1868747/664e07469fb8/1752-1947-1-19-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e463/1868747/dd323691d524/1752-1947-1-19-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e463/1868747/664e07469fb8/1752-1947-1-19-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e463/1868747/dd323691d524/1752-1947-1-19-2.jpg

相似文献

1
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report.双脱氧核苷类HIV逆转录酶抑制剂与药物相关肝毒性:一例报告
J Med Case Rep. 2007 May 8;1:19. doi: 10.1186/1752-1947-1-19.
2
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.HIV-HCV合并感染患者在高效抗逆转录病毒治疗期间肝酶升高的发生率及危险因素:来自意大利EPOKA-MASTER队列的结果
BMC Infect Dis. 2005 Jul 14;5:58. doi: 10.1186/1471-2334-5-58.
3
Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.未患病毒性肝炎的HIV患者抗逆转录病毒治疗相关的肝脏组织病理学及临床特征
Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1194-204. doi: 10.1097/MEG.0b013e328305b9e0.
4
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.接受抗逆转录病毒治疗的人类免疫缺陷病毒1型单感染患者不明原因转氨酶升高背后的肝损伤。
Hepatology. 2009 Feb;49(2):436-42. doi: 10.1002/hep.22665.
5
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.在使用去羟肌苷、司他夫定或扎西他滨进行抗逆转录病毒治疗时肝脏中线粒体DNA的耗竭。
Hepatology. 2004 Feb;39(2):311-7. doi: 10.1002/hep.20074.
6
Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.一名HIV阳性患者中与核苷类似物治疗相关的乳酸性酸中毒。
AIDS Patient Care STDS. 2000 Jul;14(7):339-42. doi: 10.1089/108729100413194.
7
Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient.一名感染人类免疫缺陷病毒(HIV)的肝移植受者在接受高效抗逆转录病毒治疗(HAART)后出现的线粒体毒性。
Liver Transpl. 2004 May;10(5):699-702. doi: 10.1002/lt.20109.
8
Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.核苷类似物抗逆转录病毒疗法继发的乳酸性酸中毒
AIDS Read. 2000 Oct;10(10):602-6.
9
Gynecomastia associated with highly active antiretroviral therapy.与高效抗逆转录病毒治疗相关的男性乳房发育
Ann Pharmacother. 2001 Apr;35(4):438-9. doi: 10.1345/aph.10274.
10
Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.肝纤维化对合并感染人类免疫缺陷病毒和丙型肝炎病毒患者高效抗逆转录病毒治疗相关肝毒性的影响。
Clin Infect Dis. 2005 Feb 15;40(4):588-93. doi: 10.1086/427216. Epub 2005 Jan 21.

引用本文的文献

1
Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.齐多夫定(AZT)与肝脏脂质蓄积:炎症、氧化和内质网应激介质的影响。
PLoS One. 2013 Oct 11;8(10):e76850. doi: 10.1371/journal.pone.0076850. eCollection 2013.

本文引用的文献

1
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy.一项关于替诺福韦酯或阿巴卡韦替代核苷类似物用于脂肪萎缩患者的随机对照试验。
AIDS. 2006 Oct 24;20(16):2043-50. doi: 10.1097/01.aids.0000247574.33998.03.
2
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.在HIV血清阳性患者中,肝脂肪变性与纤维化、核苷类似物的使用以及丙型肝炎病毒3型感染有关。
Clin Infect Dis. 2006 Aug 1;43(3):365-72. doi: 10.1086/505495. Epub 2006 Jun 22.
3
Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
抗逆转录病毒药物的肝毒性:发生率、机制及管理
J Hepatol. 2006;44(1 Suppl):S132-9. doi: 10.1016/j.jhep.2005.11.027. Epub 2005 Nov 28.
4
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.HIV-HCV合并感染患者在高效抗逆转录病毒治疗期间肝酶升高的发生率及危险因素:来自意大利EPOKA-MASTER队列的结果
BMC Infect Dis. 2005 Jul 14;5:58. doi: 10.1186/1471-2334-5-58.
5
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.感染人类免疫缺陷病毒和丙型肝炎病毒的成年人中的肝脂肪变性与抗逆转录病毒药物使用情况
AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25.
6
Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine.暴露于司他夫定的人肝癌细胞中的线粒体氧化应激
Toxicol Appl Pharmacol. 2004 Aug 15;199(1):10-9. doi: 10.1016/j.taap.2004.03.005.
7
Acute liver enzyme elevations in HIV-1-infected patients.HIV-1感染患者的急性肝酶升高
HIV Clin Trials. 2003 Nov-Dec;4(6):400-10. doi: 10.1310/2L6M-EE7G-5PGN-FJYP.
8
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.联合抗逆转录病毒治疗期间的严重肝毒性:发病率、肝脏组织学及转归
J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):259-67. doi: 10.1097/00126334-200303010-00004.
9
Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment.两名接受司他夫定(d4T)治疗的HIV感染患者出现代谢性酸中毒和肝脂肪变性。
Arch Med Res. 2003 Jan-Feb;34(1):64-9. doi: 10.1016/s0188-4409(02)00454-x.
10
Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?核苷类逆转录酶抑制剂的线粒体毒性:长期抗逆转录病毒治疗的潜在障碍?
Curr Opin Infect Dis. 2000 Feb;13(1):5-11. doi: 10.1097/00001432-200002000-00002.